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Summary: A simple and rapid method for the quantitative determination of mexiletine, using gas-liquid chromato-
graphy with nitrogen sensitive detection, is described. Only one extraction step is needed, the recovery is between
92-96% and the precision varies between 2.0-5.5%. The lower limit of detection reached 0.5 μιηοΐ/ΐ. During routine
handling the method was easy, quick and cheap.
Gaschromatographische Bestimmung von Mexiletine im Serum mit Stickstoffdetektor
Zusammenfassung: Eine einfache und schnelle Bestimmungsmethode f r Mexiletine im Serum mittels Gaschromato-
graphie mit Stickstoffdetektor wird beschrieben. Eine einmalige Extraktion ist ausreichend, die Wiederfindungsrate
betr gt 92—96%, die Genauigkeit variiert zwischen 2,0 und 5,5%. Die Nachweisgrenze liegt bei 0,5 μιηοΐ/ΐ. Im Rah-
men von Routinebestimmungen hat sich die Methode als spezifisch, zeitsparend und billig erwiesen.
Introduction
Mexiletine (l-(2,6-dimethylphenoxy)-2-aminopropane is
an anti-arrhythmic drug which is effective when adminis-
tered orally or intravenously (1, 2). Mexiletine has been
used in the treatment of acute and chronic ventricular
arrhythmias associated with various cardiac diseases
(3—6). The quantitative determination of mexiletine is
important both for monitoring and optimizing blood
levels of patients receiving therapeutic doses, and for
studying the pharrnacokinetic properties of the drug (7,
8, 9). Several gas4iquid Chromatographie methods are
available for measuring the circulating concentrations of
mexiletine (10-rl5). In addition to flame-ionization
detection (FID) (12,13) both electron-capture (EC) (11)
and nitrogen selective detection (NPD) (14,15) have
been employed. Although the methods appear to be
specific and accurate they tend to be tedious and
lengthy, and thus not suitable for the rapid manual
analysis of multiple samples. The aim of the present
study was to evaluate a simple, rapid and accurate gas-
liquid Chromatographie determination of mexiletine




propane χ Hd, K 1173C1, C. H. Boehringer Sohn, D-6507
Ingelheim am Rhein, F.R.G., MT = 214.7.
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Fig. 1. Molecule structure of mexiletine, Afr = 179.3.
Stock standard solution: 5.0 mmol/1 in distilled water. Stored at
+ 4°C.
Working standard: 2.5, 5.0,10.0 and 15.0 μηιοΐ/ΐ in pooled, drug-
free serum. Aliquots of 1 ml were stored at - 20 °C.
Internal standard, l-(2,4,6-trimethylphenoxy>2-aminopropane
X HC1, K 1307 Q, C. H. Boehiinger Sohn, D-6507 Ingelheim
am Rhein, F.R.G.
Stock solution: 4.0 mmol/1 in distilled water. Stored at + 4 °C.
Working solution: 40.0 μιηοΐ/ΐ in distilled water. Stored at
+ 4°C.
Sodium hydroxide (Merck No. 9136, E. Merck, D-6100 Darm-
stadt, F.R.G.): 2 mol/1.
Diethyl ether (Merck No. 921, E. Merck, D-6100 Darmstadt,
F.R.G.).
Acetic anhydride (Merck No. 42, E. Merck, D-6100 Darmstadt,
F.R.G.).
Methanol (Merck No. 6002, E. Merck, D-6100 Darmstadt,
F.R.G.).
Gas Chromatographie conditions
The gas chromatograms were obtained with a Varian 2100 gas
Chromatograph equipped with a flameless nitrogen/phosphorus-
sensitive detector (Thermionic Specific Detector, Varian Asso-
ciates, U.S.A.) and a Servogor RE 511 recorder (Goertz Electro,
Austria).
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The glass column (1.1 m length and 2 mm inside diameter) was
filled with 10% SP-1000 on Supelcoport 80/100 mesh (Supelco,
INC., Bellefonte, Pennsylvania 16823).
The column oven temperature was 180 °C, and the injector and
detector temperatures were both 220 °C.
The flow rates of the nitrogen carrier gas, hydrogen and air, were
20 ml/min, 4.5 ml/min and 175 ml/min respectively.
Procedure
To-a serum sample (1 ml) 200 μΐ of the internal standard solu-
tion and 400 μΐ of sodium hydroxide (2 mol/1) are added. After
mixing, the sample is extracted by shaking for 10 minutes two
times with 3 ml portions of diethyl ether. The upper ether layers
are transferred into' a tapered glass centrifuge tube. To make the
acetyl derivative of mexiletine 25 μΐ of acetic anhydride is added
to the ether solution. The ether is evaporated off in a thermo-
stated bath at 40 °C. The residue is dissolved in 25 μΐ of metha-
nol using a vortex mixer. Aliquots of 1 μΐ are injected into the
gas Chromatograph.
Working serum standards are processed for each batch of
samples. A four-point calibration curve is constructed from
which the mexiletine concentrations are read. TThe retention
times for mexiletine is 1.8 min and for the internal standard
2.3 min. Linearity is good from 0.5 μηιοΐ/ΐ to 40.0 μηιοΙ/1.
IS
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Fig. 2. Gas chromatograms:
a) blank serum
b) serum containing 0.5 μηιοΐ/ΐ mexiletine (M)
c) serum containing 2.5 μηιοΐ/ΐ mexiletine (M)
d) serum containing 7.3 μιηοΐ/ΐ mexiletine (M)
IS = Internal standard
or in serum from patients treated with digitalis, beta-
blockers, benzodiazepines or different diuretics.
In order to test the sensitivity of the method in sensitiv-
ity studies a drug free serum was spiked with mexiletine
to a concentration of 0.5 μιηοΐ/ΐ and processed as de-
scribed above. The limit of detection was shown to be
less than 0.5 μιηοΐ/l.
Recovery
Recovery of mexiletine from serum was studied by
adding known quantities of mexiletine to a pre-analysed
serum pool. The concentration obtained is given as a
percentage of the calculated concentration. This was
carried out for two concentrations of added mexiletine.
Ten samples were analysed at both concentrations.





















Within-run precision was calculated from measurements
at three different concentrations.
Day-to-day precision was calculated from mexiletine
analysis of a pooled serum over a period of two months.


























Representative chromatograms of serum samples ex-
tracted according to our procedure are presented in
figure 1. Chromatogram (a) is a pattern typical'of the
serum of a normal individual not receiving drugs. Chro-
matogram (b) is obtained from a standard solution (in
serum) containing 0.5 μπιοΐ/ΐ mexiletine. Chromatogram
(c) and (d) are obtained from a patient who first re-
ceived 3 X 200 mg mexiletine (c) and then 2 X 400 mg
mexiletine a day (d) resulting in serum concentrations
of 2.5 μιηοΐ/ΐ and 7.3 μιηοΐ/ΐ respectively. No inter-
ference was found from endogenous serum constituents,
Conclusion
Gas-liquid chromatography with nitrogen-sensitive detec-
tion of the acetyl derivative of mexiletine provides a
rapid and specific method for estimation of its con-
centration in serum. The method described has been
found suitable for routine monitoring of serum con-
centrations in patients receiving mexiletine. The nitrogen
sensitive detector has the advantages of a much smaller
solvent front, increased sensitivity to nitrogen-containing
compounds and decreased interference from compounds
which do riot contain-nitrogen. Analyses can thus be
J. C n. Chem. Clin. Bipchem. / Vol. 19,1981 / No. 12
Elfving, Svens and Leskinen: Gas-liquid Chromatographie determination of mexiletine 1191
completed in a shorter time when using a conventional
flame detector. For those laboratories in which a gas
Chromatograph with a nitrogen sensitive detector is
available, the present method is fast and simple, while
retaining good accuracy and precision. Complete analysis
time for an urgent determination is 1.5 hours, while in
routine analysis the determination of 30 serum samples
may be performed in a normal working day.
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